Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance.

Goel, Arun Kumar; Zamre, Vaishali; Sharma, Gopal; Singh, Dinesh; Chaudhary, Prekshi

Goel, Arun Kumar; Zamre, Vaishali; Sharma, Gopal; Singh, Dinesh; Chaudhary, Prekshi.

Afiliación

Goel AK; Department of Surgical Oncology, Max Superspecialty Hospital, Vaishali, India. Electronic address: arun.goel07@gmail.com.
Zamre V; Department of Surgical Oncology, Max Superspecialty Hospital, Vaishali, India.
Sharma G; Department of Medical Oncology, Max Superspecialty Hospital, Vaishali, India.
Singh D; Department of Radiation Oncology, Max Superspecialty Hospital, Vaishali, India.
Chaudhary P; Department of Radiation Oncology, Max Superspecialty Hospital, Vaishali, India.

Clin Breast Cancer ; 21(1): 92-93, 2021 02.

Article en En | MEDLINE | ID: mdl-33187863

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama/diagnóstico; Femenino; Humanos; Pronóstico; Receptor ErbB-2; Receptores de Progesterona

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google